IPLTF (Implantica AG) Asset Impairment Charge: $0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Implantica AG Asset Impairment Charge?

Implantica AG IPLTF Asset Impairment Charge is $0.00 Mil as of . 20.

Implantica AG's Asset Impairment Charge for the six months ended in . 20 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Implantica AG Asset Impairment Charge Related Terms

Implantica AG Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for Implantica AG's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Implantica AG Asset Impairment Charge Chart

Implantica AG Annual Data
Trend
Asset Impairment Charge

Implantica AG Semi-Annual Data
Asset Impairment Charge

Implantica AG Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

What does a Asset Impairment Charge of $0.00 Mil mean?
Implantica AG (IPLTF) has a Asset Impairment Charge of $0.00 Mil as of . 20.
Is Implantica AG's Asset Impairment Charge too high?
Implantica AG's current Asset Impairment Charge is $0.00 Mil.
How does Implantica AG's Asset Impairment Charge compare to ?
Implantica AG's Asset Impairment Charge of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Medical Devices & Instruments company?
A good Asset Impairment Charge depends on the Medical Devices & Instruments industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. Implantica AG's current Asset Impairment Charge is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (IPLTF) has a current Asset Impairment Charge of $0.00 Mil. The current Asset Impairment Charge is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For Implantica AG (IPLTF), the current Asset Impairment Charge is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Implantica AG Business Description

Comparable Companies
Other Exchanges IMP A SDB:Sweden
Address Aeulestrasse 15, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.